DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Leroy V, Angus P, Bronowicki JP. , et al.
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY-3+).
Hepatology 2016;
63 (05) 1430-1441
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.